Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin

Aim: To compare ultrastructure, phenotypic profile and cell cycle progression ofMCF-7 human breast cancer cells and MCF7 sublines resistant to cisplatin (MCF-7/DDP) and doxorubicin (MCF-7/DOX). Methods: MTT-test, immunocytochemistry, flow cytometry, electron microscopy. Results: Th...

Full description

Saved in:

Bibliographic Details
Published in:	Experimental Oncology
Date:	2009
Main Authors:	Lukyanova, N.Yu., Rusetskya, N.V., Tregubova, N.A., Chekhun, V.F.
Format:	Article
Language:	English
Published:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2009
Subjects:	Original contributions
Online Access:	https://nasplib.isofts.kiev.ua/handle/123456789/135701
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:	Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin / N.Yu. Lukyanova, N.V. Rusetskya, N.A. Tregubova, V.F. Chekhun // Experimental Oncology. — 2009. — Т. 31, № 2. — С. 87–91. — Бібліогр.: 26 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Similar Items

Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)

Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)

Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
by: Boroday, N.V., et al.
Published: (2018)

Association of Rictor with chromosomes during mitosis in MCF7 cells
by: Malanchuk, O.M.
Published: (2015)

Association of Rictor with chromosomes during mitosis in MCF7 cells
by: O. M. Malanchuk
Published: (2015)

Low-density microarray analysis of TGFβ1-dependent cell cycle regulation in human breast adenocarcinoma MCF7 cell line
by: Dubrovska, A.M., et al.
Published: (2014)

Low-density microarray analysis of TGFв1-dependent cell cycle regulation in human breast adenocarcinoma MCF7 cell line
by: A. M. Dubrovska, et al.
Published: (2014)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)

Comparison of Mesenchymal Stem Cells and αIFN Effects on Functioning of MCF-7 Cancer Cell Population
by: T. S. Gergeljuk, et al.
Published: (2012)

HTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells
by: Sakin, V., et al.
Published: (2008)

Effect of progesterone on the MGMT gene expression in MCF7, HEp-2 and 293 cells
by: Z. M. Nidoieva, et al.
Published: (2020)

Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma MCF-7 cells
by: B. O. Vynnytska-Myronovska, et al.
Published: (2014)

Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016)

ITSN1 and Ruk/CIN85 colocalized to clathrin-coated pits in MCF-7 cells
by: Nikolaienko, O.V., et al.
Published: (2009)

Adaptor protein Ruk/CIN85 participates in the metabolic control of human breast adenocarcinoma MCF-7 cells
by: R. S. Korshun, et al.
Published: (2022)

Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018)

Influence of fullerenes C60 on the survivability of breast cancer cell line MCF-7 during Long-term incubation
by: I. I. Hryniuk, et al.
Published: (2010)

Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells
by: A. Hussain, et al.
Published: (2014)

Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells
by: Hussain, A., et al.
Published: (2014)

In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013)

Prevention of cisplatin toxicity against normal cells by complexation with C60 fullerene
by: S. V. Prylutska, et al.
Published: (2020)

Synergistic effects of taurine and cisplatin on lung cancer cells (A549)
by: F. J. Jouni, et al.
Published: (2023)

Interaction of nanoscale doxorubicin conjugates with proteins and cells of peripheral human blood
by: Yu. Ya. Kit, et al.
Published: (2012)

Effect of cytostatic agents on expression levels of human beta-defensins-1-4 in A431 and MCF-7 cell lines
by: Zubenko, O.S., et al.
Published: (2018)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: S. Chekhun, et al.
Published: (2013)

Activation of store – operated Ca2+ entry in cisplatin resistant leukemic cells after treatment with photoexcited fullerene C60 and cisplatin
by: D. V. Franskevych, et al.
Published: (2018)

Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)

Transcriptional regulation of NOX genes expression in human breast adenocarcinoma MCF-7 cells is modulated by adaptor protein Ruk/CIN85
by: A. V. Bazalii, et al.
Published: (2016)

The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and В16 melanoma resistant to doxorubicin
by: Berezhnaya, N.M., et al.
Published: (2008)

Molecular profile of gastric cancer as a basis of individualized treatment and prognosis of disease outcome
by: Demash, D.V., et al.
Published: (2011)

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)

Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)

Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin
by: L. A. Naleskina, et al.
Published: (2013)

Action of doxorubicin delivered to tumor cells in vitroand in vivo by novel nanoscale oligoelectrolytic carrier
by: N. M. Boiko, et al.
Published: (2013)

Using the combined chemo-immunotherapy based on dendritic cells and low-dose doxorubicin in experiment
by: O. I. Horbach, et al.
Published: (2013)